Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/RP5063> ?p ?o }
Showing triples 1 to 91 of
91
with 100 triples per page.
- RP5063 abstract "RP5063, also known as RP5000, is an investigational atypical antipsychotic which is under development by Reviva Pharmaceuticals for the treatment of schizophrenia and schizoaffective disorder. Reviva Pharmaceuticals also intends to investigate RP5063 for the treatment of bipolar disorder, major depressive disorder, psychosis/agitation associated with Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder (ADD/ADHD), and autism. As of May 2015, it is in phase III clinical trials for schizophrenia.".
- RP5063 wikiPageExternalLink 800035778.
- RP5063 wikiPageExternalLink product_pipeline.
- RP5063 wikiPageID "46753436".
- RP5063 wikiPageLength "6488".
- RP5063 wikiPageOutDegree "53".
- RP5063 wikiPageRevisionID "682825414".
- RP5063 wikiPageWikiLink 5-HT1A_receptor.
- RP5063 wikiPageWikiLink 5-HT1B_receptor.
- RP5063 wikiPageWikiLink 5-HT2A_receptor.
- RP5063 wikiPageWikiLink 5-HT2C_receptor.
- RP5063 wikiPageWikiLink 5-HT3_receptor.
- RP5063 wikiPageWikiLink 5-HT6_receptor.
- RP5063 wikiPageWikiLink 5-HT7_receptor.
- RP5063 wikiPageWikiLink Affinity_(pharmacology).
- RP5063 wikiPageWikiLink Alpha-1B_adrenergic_receptor.
- RP5063 wikiPageWikiLink Alpha-2_adrenergic_receptor.
- RP5063 wikiPageWikiLink Alzheimers_disease.
- RP5063 wikiPageWikiLink Aripiprazole.
- RP5063 wikiPageWikiLink Attention_deficit_hyperactivity_disorder.
- RP5063 wikiPageWikiLink Atypical_antipsychotic.
- RP5063 wikiPageWikiLink Autism.
- RP5063 wikiPageWikiLink Bifeprunox.
- RP5063 wikiPageWikiLink Bipolar_disorder.
- RP5063 wikiPageWikiLink Brexpiprazole.
- RP5063 wikiPageWikiLink Cariprazine.
- RP5063 wikiPageWikiLink Category:5-HT1A_agonists.
- RP5063 wikiPageWikiLink Category:5-HT2A_agonists.
- RP5063 wikiPageWikiLink Category:5-HT6_antagonists.
- RP5063 wikiPageWikiLink Category:5-HT7_antagonists.
- RP5063 wikiPageWikiLink Category:Atypical_antipsychotics.
- RP5063 wikiPageWikiLink Category:D2-receptor_agonists.
- RP5063 wikiPageWikiLink Category:Dopamine_agonists.
- RP5063 wikiPageWikiLink Category:Serotonin_reuptake_inhibitors.
- RP5063 wikiPageWikiLink Clinical_trial.
- RP5063 wikiPageWikiLink D1_receptor.
- RP5063 wikiPageWikiLink D2_receptor.
- RP5063 wikiPageWikiLink D3_receptor.
- RP5063 wikiPageWikiLink D4_receptor.
- RP5063 wikiPageWikiLink D5_receptor.
- RP5063 wikiPageWikiLink Dopamine.
- RP5063 wikiPageWikiLink Dopamine_receptor_D1.
- RP5063 wikiPageWikiLink Dopamine_receptor_D2.
- RP5063 wikiPageWikiLink Dopamine_receptor_D3.
- RP5063 wikiPageWikiLink Dopamine_receptor_D4.
- RP5063 wikiPageWikiLink Dopamine_receptor_D5.
- RP5063 wikiPageWikiLink Dopamine_transporter.
- RP5063 wikiPageWikiLink Histamine_H1_receptor.
- RP5063 wikiPageWikiLink ITI-007.
- RP5063 wikiPageWikiLink Ligand_(biochemistry).
- RP5063 wikiPageWikiLink Lurasidone.
- RP5063 wikiPageWikiLink Major_depressive_disorder.
- RP5063 wikiPageWikiLink Muscarinic_acetylcholine_receptor.
- RP5063 wikiPageWikiLink Neurotransmitter.
- RP5063 wikiPageWikiLink Norepinephrine_transporter.
- RP5063 wikiPageWikiLink Parkinsons_disease.
- RP5063 wikiPageWikiLink Partial_agonist.
- RP5063 wikiPageWikiLink Phases_of_clinical_research.
- RP5063 wikiPageWikiLink Psychomotor_agitation.
- RP5063 wikiPageWikiLink Psychosis.
- RP5063 wikiPageWikiLink Receptor_antagonist.
- RP5063 wikiPageWikiLink Reviva_Pharmaceuticals.
- RP5063 wikiPageWikiLink Schizoaffective_disorder.
- RP5063 wikiPageWikiLink Schizophrenia.
- RP5063 wikiPageWikiLink Serotonin.
- RP5063 wikiPageWikiLink Serotonin_transporter.
- RP5063 wikiPageWikiLinkText "RP5063".
- RP5063 hasPhotoCollection RP5063.
- RP5063 wikiPageUsesTemplate Template:Antipsychotics.
- RP5063 wikiPageUsesTemplate Template:Drugbox.
- RP5063 wikiPageUsesTemplate Template:Histaminergics.
- RP5063 wikiPageUsesTemplate Template:Nervous-system-drug-stub.
- RP5063 wikiPageUsesTemplate Template:Reflist.
- RP5063 subject Category:5-HT1A_agonists.
- RP5063 subject Category:5-HT2A_agonists.
- RP5063 subject Category:5-HT6_antagonists.
- RP5063 subject Category:5-HT7_antagonists.
- RP5063 subject Category:Atypical_antipsychotics.
- RP5063 subject Category:D2-receptor_agonists.
- RP5063 subject Category:Dopamine_agonists.
- RP5063 subject Category:Serotonin_reuptake_inhibitors.
- RP5063 type ChemicalSubstance.
- RP5063 type Drug.
- RP5063 type ChemicalObject.
- RP5063 type Thing.
- RP5063 type Q8386.
- RP5063 comment "RP5063, also known as RP5000, is an investigational atypical antipsychotic which is under development by Reviva Pharmaceuticals for the treatment of schizophrenia and schizoaffective disorder. Reviva Pharmaceuticals also intends to investigate RP5063 for the treatment of bipolar disorder, major depressive disorder, psychosis/agitation associated with Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder (ADD/ADHD), and autism.".
- RP5063 label "RP5063".
- RP5063 sameAs m.0138tg1m.
- RP5063 wasDerivedFrom RP5063?oldid=682825414.
- RP5063 isPrimaryTopicOf RP5063.